Stuart Essig insider trades

Open-market stock purchases and sales by Stuart Essig, President and CEO at Integra Lifesciences Holdings Corp, from SEC Form 4 filings since Mar 4, 2010.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -67%.

Recent trades

DateStockTradeValue
Jun 1, 2026IART Integra Lifesciences Holdings CorpBought (not open market)—
Jun 1, 2026IART Integra Lifesciences Holdings CorpBought (not open market)—
May 20, 2026PIPR Piper Sandler CompaniesBought (not open market)—
May 12, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—
May 12, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—
Feb 4, 2026PIPR Piper Sandler CompaniesBought (not open market)—
Oct 30, 2025DYNT Dynatronics CorpBought (not open market)—
Oct 30, 2025DYNT Dynatronics CorpBought (not open market)—

Companies traded

  • IART Integra Lifesciences Holdings Corp: 1 buy, 53 sales, last Jun 1, 2026
  • PIPR Piper Sandler Companies: other filings, last May 20, 2026
  • IDXX Idexx Laboratories Inc /DE: other filings, last May 12, 2026
  • DYNT Dynatronics Corp: 48 buys, last Oct 30, 2025
  • OFIX Orthofix Medical Inc: other filings, last Jan 5, 2023
  • SPNE SeaSpine Holdings Corp: 4 buys, 1 sale, last Jan 5, 2023
  • OMI Owens & Minor Inc/va/: 1 buy, last Jun 28, 2019
  • STJ ST Jude Medical, LLC: 6 sales, last Jan 4, 2017

Get free alerts when Stuart Essig files a new trade →